Evaluation of Side-Effects after 131I-therapy for Differentiated Thyroid Carcinoma

Journal of West China University of Medical Sciences

Volumn 31, Issue 2, 2000, Pages 197-199

  Pan, Mingzhi ^a   Tan, Tianzhi ^a   Guan, Changtian ^a  

^a FIRST AFFILIATED HOSPITAL   (China)

Author keywords

131I therapy; Differentiated thyroid carcinoma; Side effects

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; RADIOISOTOPE THERAPY; SIALOADENITIS; THYROID CARCINOMA; THYROIDITIS; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; NAUSEA; POSTOPERATIVE PERIOD; RADIATION INJURY; RADIOTHERAPY; THYROID TUMOR;

ADENOCARCINOMA, PAPILLARY; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NAUSEA; POSTOPERATIVE PERIOD; RADIATION INJURIES; RADIOTHERAPY; SIALADENITIS; THYROID NEOPLASMS; THYROIDITIS;

EID: 0033947891     PISSN: 02577712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. 131I therapy for differentiated thyroid cancer. J Nucl Med, 19941; 35(1): 15
2. Leeper RD, Shimaoka K. Treatment of metastatic thyroid cancer. Clin Endocrinol Metab, 1980; 9(3): 383
3. Lin WY, Shen YY, Wang SJ. Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med, 1996; 21(10): 780
4. 131I and chloride in mixed human saliva. J Clin Invest, 1953; 32: 1077
5. 131I therapy for thyroid carcinoma. J Nucl Med, 1984; 25(10): 755
6. 131I radioablation for well-differentiated thyroid cancer. Surgery, 1994; 116: 1024
7. Keldsen N, Mortenson BT, Hansen HS. Haematological effects from radioiodine treatment of thyroid carcinoma. Acta Oncol, 1999; 29: 1035
8. Clark SEM. Radionuclide therapy of the thyroid. Eur J Nucl Med, 1991; 18: 984
9. Dottorini ME, Lomuscio G, Mazzucchelli L, et al. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med, 1995, 36(1): 21